- £5.05bn
- £5.79bn
- £1.67bn
- 83
- 26
- 94
- 82
Annual balance sheet for Spirax, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 246 | 275 | 329 | 360 | 338 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 254 | 309 | 409 | 355 | 364 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 693 | 804 | 1,054 | 1,025 | 987 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 298 | 340 | 452 | 514 | 529 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,745 | 1,863 | 2,785 | 2,708 | 2,645 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 228 | 382 | 638 | 454 | 533 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 890 | 854 | 1,616 | 1,552 | 1,436 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 855 | 1,009 | 1,169 | 1,157 | 1,209 |
| Total Liabilities & Shareholders' Equity | 1,745 | 1,863 | 2,785 | 2,708 | 2,645 |
| Total Common Shares Outstanding |